CVRx, Inc. (CVRX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
33/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseCVRX / S&P -45.67% / 15.20% |
LoseCVRX / S&P 11.96% / 15.00% |
LoseCVRX / S&P -4.83% / 50.40% |
| 2026-Q12/3 |
WinCVRX / S&P 33.24% / -4.33% |
WinCVRX / S&P 11.73% / 11.30% |
LoseCVRX / S&P -6.51% / 27.70% |
| 2025-Q41/3 |
LoseCVRX / S&P -12.02% / 2.65% |
WinCVRX / S&P 10.45% / 9.00% |
LoseCVRX / S&P -23.31% / 13.40% |
| 2025-Q32/3 |
WinCVRX / S&P 37.24% / 8.12% |
WinCVRX / S&P 18.44% / 4.61% |
LoseCVRX / S&P -26.30% / 13.45% |
| 2025-Q21/3 |
LoseCVRX / S&P -51.92% / 10.94% |
WinCVRX / S&P 23.11% / 4.83% |
LoseCVRX / S&P -19.14% / 10.63% |
| 2025-Q12/3 |
WinCVRX / S&P -3.47% / -4.27% |
WinCVRX / S&P 25.62% / 4.98% |
LoseCVRX / S&P -12.96% / 10.57% |
| 2024-Q43/3 |
WinCVRX / S&P 43.81% / 2.41% |
WinCVRX / S&P 30.53% / 5.25% |
WinCVRX / S&P 34.34% / 6.15% |
| 2024-Q32/3 |
LoseCVRX / S&P -26.52% / 5.89% |
WinCVRX / S&P 34.38% / 5.89% |
WinCVRX / S&P 31.71% / 6.11% |
| 2024-Q22/3 |
LoseCVRX / S&P -34.16% / 4.28% |
WinCVRX / S&P 43.94% / 5.38% |
WinCVRX / S&P 21.90% / 5.12% |
| 2024-Q12/3 |
LoseCVRX / S&P -42.08% / 10.56% |
WinCVRX / S&P 59.59% / 5.71% |
WinCVRX / S&P 18.75% / 5.59% |
| 2023-Q42/3 |
WinCVRX / S&P 107.25% / 11.69% |
WinCVRX / S&P 74.89% / 6.81% |
LoseCVRX / S&P -1.98% / 7.78% |
| 2023-Q33/3 |
WinCVRX / S&P -1.75% / -3.27% |
WinCVRX / S&P 85.56% / 7.52% |
WinCVRX / S&P 102.97% / -5.03% |
| 2023-Q23/3 |
WinCVRX / S&P 65.67% / 8.74% |
WinCVRX / S&P 90.85% / 9.50% |
WinCVRX / S&P 153.01% / -8.57% |
| 2023-Q11/3 |
LoseCVRX / S&P -49.21% / 7.50% |
WinCVRX / S&P 85.04% / 10.77% |
LoseCVRX / S&P -95.74% / -15.69% |
| 2022-Q42/3 |
WinCVRX / S&P 96.68% / 7.56% |
WinCVRX / S&P 72.36% / 11.88% |
LoseCVRX / S&P -97.20% / -17.99% |
| 2022-Q32/3 |
WinCVRX / S&P 55.24% / -4.88% |
WinCVRX / S&P 65.28% / 13.47% |
LoseCVRX / S&P CVRX unavailable / -1.41% |
| 2022-Q22/3 |
WinCVRX / S&P 0.33% / -16.10% |
WinCVRX / S&P 78.21% / 13.71% |
LoseCVRX / S&P CVRX unavailable / 11.04% |
| 2022-Q11/3 |
LoseCVRX / S&P -51.02% / -4.60% |
WinCVRX / S&P 98.08% / 15.97% |
LoseCVRX / S&P CVRX unavailable / 42.23% |
| 2021-Q40/3 |
LoseCVRX / S&P -26.06% / 11.03% |
LoseCVRX / S&P CVRX unavailable / 15.00% |
LoseCVRX / S&P CVRX unavailable / 96.40% |
| 2021-Q30/3 |
LoseCVRX / S&P -40.93% / 0.58% |
LoseCVRX / S&P CVRX unavailable / 10.77% |
LoseCVRX / S&P CVRX unavailable / 69.42% |
| 2021-Q20/3 |
LoseCVRX / S&P CVRX unavailable / 8.55% |
LoseCVRX / S&P CVRX unavailable / 6.58% |
LoseCVRX / S&P CVRX unavailable / 51.81% |
| 2021-Q10/3 |
LoseCVRX / S&P CVRX unavailable / 6.17% |
LoseCVRX / S&P CVRX unavailable / -1.06% |
LoseCVRX / S&P CVRX unavailable / 7.39% |
| 2020-Q40/3 |
LoseCVRX / S&P CVRX unavailable / 12.15% |
LoseCVRX / S&P CVRX unavailable / -3.72% |
LoseCVRX / S&P CVRX unavailable / -33.42% |
| 2020-Q30/3 |
LoseCVRX / S&P CVRX unavailable / 8.93% |
LoseCVRX / S&P CVRX unavailable / -2.04% |
LoseCVRX / S&P CVRX unavailable / -27.10% |
| 2020-Q20/3 |
LoseCVRX / S&P CVRX unavailable / 20.54% |
LoseCVRX / S&P CVRX unavailable / -0.46% |
LoseCVRX / S&P CVRX unavailable / -27.11% |
| 2020-Q10/3 |
LoseCVRX / S&P CVRX unavailable / -19.60% |
LoseCVRX / S&P CVRX unavailable / 3.47% |
LoseCVRX / S&P CVRX unavailable / -14.75% |
| 2019-Q40/3 |
LoseCVRX / S&P CVRX unavailable / 9.07% |
LoseCVRX / S&P CVRX unavailable / 5.36% |
LoseCVRX / S&P CVRX unavailable / 2.99% |
| 2019-Q30/3 |
LoseCVRX / S&P CVRX unavailable / 1.70% |
LoseCVRX / S&P CVRX unavailable / 5.02% |
LoseCVRX / S&P CVRX unavailable / 0.21% |
| 2019-Q20/3 |
LoseCVRX / S&P CVRX unavailable / 4.30% |
LoseCVRX / S&P CVRX unavailable / 6.64% |
LoseCVRX / S&P CVRX unavailable / 8.65% |
| 2019-Q10/3 |
LoseCVRX / S&P CVRX unavailable / 13.65% |
LoseCVRX / S&P CVRX unavailable / 8.12% |
LoseCVRX / S&P CVRX unavailable / 14.29% |
| 2018-Q40/3 |
LoseCVRX / S&P CVRX unavailable / -13.52% |
LoseCVRX / S&P CVRX unavailable / 9.05% |
LoseCVRX / S&P CVRX unavailable / 18.23% |
| 2018-Q30/3 |
LoseCVRX / S&P CVRX unavailable / 7.71% |
LoseCVRX / S&P CVRX unavailable / 10.21% |
LoseCVRX / S&P CVRX unavailable / 19.06% |
| 2018-Q20/3 |
LoseCVRX / S&P CVRX unavailable / 3.43% |
LoseCVRX / S&P CVRX unavailable / 9.03% |
LoseCVRX / S&P CVRX unavailable / 14.46% |
| 2018-Q10/3 |
LoseCVRX / S&P CVRX unavailable / -0.76% |
LoseCVRX / S&P CVRX unavailable / 7.68% |
LoseCVRX / S&P CVRX unavailable / 12.46% |
| 2017-Q40/3 |
LoseCVRX / S&P CVRX unavailable / 6.64% |
LoseCVRX / S&P CVRX unavailable / 7.03% |
LoseCVRX / S&P CVRX unavailable / 13.82% |
| 2017-Q30/3 |
LoseCVRX / S&P CVRX unavailable / 4.48% |
LoseCVRX / S&P CVRX unavailable / 5.68% |
LoseCVRX / S&P CVRX unavailable / 17.57% |
| 2017-Q20/3 |
LoseCVRX / S&P CVRX unavailable / 3.09% |
LoseCVRX / S&P CVRX unavailable / 4.83% |
LoseCVRX / S&P CVRX unavailable / 17.74% |
| 2017-Q10/3 |
LoseCVRX / S&P CVRX unavailable / 6.07% |
LoseCVRX / S&P CVRX unavailable / 3.67% |
LoseCVRX / S&P CVRX unavailable / 13.32% |
| 2016-Q40/3 |
LoseCVRX / S&P CVRX unavailable / 3.82% |
LoseCVRX / S&P CVRX unavailable / 2.09% |
LoseCVRX / S&P CVRX unavailable / 7.05% |
| 2016-Q30/3 |
LoseCVRX / S&P CVRX unavailable / 3.85% |
LoseCVRX / S&P CVRX unavailable / 0.20% |
LoseCVRX / S&P CVRX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CVRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -61.27% | 20.78% |
| Annualized return | -61.27% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CVRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -84.22% | 83.14% |
| Annualized return | -30.88% | 12.86% |
10Y · 2021-06-30 to 2026-08-27
| Metric | CVRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -89.14% | 319.30% |
| Annualized return | -19.91% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |